Find out about the latest clinical trials for cancer patients, including novel immunotherapy approaches.
MARCH 2017
Providence Cancer Center is currently conducting more than 160 research studies, including trials of targeted therapies and novel immunotherapy approaches. Please see the links below for a list of studies in specific disease areas.
Highlight: Targeted therapy and immunotherapy studies for people with lung cancer
More than 20 studies of promising new therapies for lung cancer patients are open now at Providence Cancer Center, including studies of targeted therapies and novel immunotherapy combinations. Some are open to patients who have received prior immunotherapy. The following featured studies are either specifically for lung cancer, or for multiple types including lung cancer:
